Stocks to sell

GameStop (NYSE:GME) stock has been one of 2021’s most incredible investing stories. The initial short squeeze was incredible to watch. Few market analysts could have ever imagined that a struggling mall retailer like GameStop could see its shares surge thousands of percent. Source: rblfmr / Shutterstock.com That surge, in turn, saved the company. GameStop raised
0 Comments
A decade ago, after returning to finance from 30 years covering computer technology, I got into an argument over a company called Dendreon. You’ll see why this lingering thoughts connects me to BIIB stock below. Source: PictureDesignSwiss / Shutterstock.com Dendreon had launched a treatment for prostate cancer called Provenge. It is an immunotherapy, tied to
0 Comments
In a matter of weeks, DiDi Global (NYSE:DIDI) stock has gone from a hot IPO to an undeniable disaster. Soon after its debut on the U.S. stock market at an initial price of $14 per share, the China-based ride-hailing company was hit hard by the  Chinese government’s decision to investigate and penalize it. The shares
0 Comments
What happens if you hold onto a short squeeze stock long after the short squeeze has ended? Clover Health (NASDAQ:CLOV) stock is giving traders a demonstration. And it isn’t pretty. Since early June, when Clover peaked, shares have lost two-thirds of their value amid an unrelenting sell-off. Source: Shutterstock And, unfortunately, there’s little sign that the
0 Comments
A deep dive into SoFi Technologies (NASDAQ:SOFI) stock provides reason enough not to get on board. Those fundamentals will provide the backbone of my argument against investing in SoFi.  Source: rafapress / Shutterstock.com I would argue that potential investors avoid the buzz and buzzwords around the SPAC gone public financial services company. Specifically, I’d urge investors,
0 Comments
Prior to the U.S. Postal Service making its announcement regarding which company will replace its aging fleet of mail carriers, Workhorse (NASDAQ:WKHS) showed great promise. As the only fully electric-based proposal, the company aligned perfectly with the zero-emissions sentiment that was gradually building bipartisan support. Thus, WKHS stock appeared a no-brainer. Source: Shutterstock As it
0 Comments
Inarguably, one of the current century’s biggest investment narratives has been the rise of China stocks. Once a mess of an economy suffering from an identity crisis, the Asian juggernaut embraced Western-style capitalism — at least in its business dealings. Quickly, the so-called Chinese miracle occurred, catapulting the nation to an economic powerhouse second only
0 Comments
Mind Medicine (NASDAQ:MNMD) is a clinical-stage biotech company that is developing multiple psychedelic treatments for various mental health conditions. With numerous therapy programs in development, the goal is to effectively leverage the latest innovations to develop medicines that have never been commercialized previously. However, with no revenues, mounting losses, and an array of business risks,
0 Comments
In any other circumstance, Opendoor Technologies (NASDAQ:OPEN) stock may have been a no-brainer investment. Source: PREMIO STOCK/Shutterstock.com As you probably know, owning real estate is the epitome of the American Dream — but the paperwork to seal the deal is a veritable nightmare. Opendoor’s digitalization of the buying and selling process is the answer we’ve
0 Comments
Small biotech companies such as Denmark’s Orphazyme (NASDAQ:ORPH) usually have one major product, which pushes them into the spotlight. For ORPH stock, that one product is Arimoclomol. Source: Iryna Imago / Shutterstock.com Arimoclomol is a drug that could treat the rare progressive genetic disorder called Niemann-Pick Disease Type C (NPC). Investors looking for a breakthrough
0 Comments